Better choice company signs binding letter of intent to acquire choice specialty pharmacy, expanding u.s. presence

Tampa, fla., march 11, 2025 (globe newswire) -- better choice company, inc. (nyse american: bttr) (“better choice” or the “company”), a pet health and wellness company, today announced that it has signed a binding letter of intent (loi) to acquire 100% of choice specialty pharmacy group (“seller”), a fully licensed and prominent provider of specialized pharmacy services in the u.s., through an option purchase agreement. this acquisition is expected to further strengthen better choice's specialty pharmacy presence in the u.s. and the purchase price is based on 6x of seller's fy2024 adjusted ebitda1 of approximately usd $4.68 million1, and consideration will be comprised of stock and cash at closing.
BTTR Ratings Summary
BTTR Quant Ranking